Smith Salley & Associates decreased its stake in shares of Clorox Co (NYSE:CLX) by 6.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,554 shares of the company’s stock after selling 919 shares during the period. Smith Salley & Associates’ holdings in Clorox were worth $1,888,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of the stock. Parnassus Investments CA increased its position in Clorox by 1.6% during the second quarter. Parnassus Investments CA now owns 4,711,970 shares of the company’s stock worth $637,294,000 after purchasing an additional 76,149 shares during the last quarter. Macquarie Group Ltd. increased its position in Clorox by 437,400.0% during the second quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock worth $236,688,000 after purchasing an additional 1,749,600 shares during the last quarter. Schroder Investment Management Group increased its position in Clorox by 57.0% during the second quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock worth $201,641,000 after purchasing an additional 547,070 shares during the last quarter. Morgan Stanley increased its position in Clorox by 44.2% during the second quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock worth $148,962,000 after purchasing an additional 337,621 shares during the last quarter. Finally, Swiss National Bank increased its position in Clorox by 1.9% during the second quarter. Swiss National Bank now owns 955,992 shares of the company’s stock worth $129,298,000 after purchasing an additional 17,600 shares during the last quarter. 78.35% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently issued reports on CLX shares. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, October 3rd. Argus raised shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective for the company in a research report on Tuesday, September 25th. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. BMO Capital Markets reissued a “buy” rating and issued a $153.00 price objective on shares of Clorox in a research report on Friday, August 3rd. Finally, Barclays set a $131.00 price objective on shares of Clorox and gave the stock a “hold” rating in a research report on Saturday, October 6th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company. Clorox presently has a consensus rating of “Hold” and a consensus price target of $141.64.
Clorox stock opened at $158.77 on Friday. Clorox Co has a 52-week low of $113.57 and a 52-week high of $159.17. The firm has a market capitalization of $20.25 billion, a PE ratio of 25.36, a price-to-earnings-growth ratio of 3.89 and a beta of 0.28. The company has a quick ratio of 0.65, a current ratio of 1.07 and a debt-to-equity ratio of 3.38.
Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.03. The business had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.46 earnings per share. Research analysts anticipate that Clorox Co will post 6.31 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be paid a $0.96 dividend. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 annualized dividend and a dividend yield of 2.42%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.
In other news, SVP Michael R. Costello sold 9,265 shares of the company’s stock in a transaction on Monday, August 13th. The shares were sold at an average price of $140.02, for a total value of $1,297,285.30. Following the completion of the transaction, the senior vice president now directly owns 34,293 shares in the company, valued at $4,801,705.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Linda J. Rendle sold 382 shares of the company’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $148.32, for a total transaction of $56,658.24. The disclosure for this sale can be found here. Insiders sold 96,353 shares of company stock valued at $14,762,793 over the last 90 days. Insiders own 1.40% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.thelincolnianonline.com/2018/11/10/clorox-co-clx-shares-sold-by-smith-salley-associates.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: What Does Beta Mean In Stock Selection
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.